Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.

<h4>Purpose</h4> <p>We have identified human medicinal products for which animal data were used as evidence for withdrawal, determined whether the adverse reactions were reported in humans, established whether confirmatory human studies were conducted, and explored the withdrawal...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Onakpoya, I, Heneghan, C, Aronson, J
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Wiley 2017

Παρόμοια τεκμήρια

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2016)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2016)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
ανά: Onakpoya, IJ, κ.ά.
Έκδοση: (2016)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2017)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
ανά: Igho J. Onakpoya, κ.ά.
Έκδοση: (2019-03-01)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
ανά: Onakpoya, I
Έκδοση: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2017)

The Adverse Drug Reactions Registered During the Postmarketing Period
ανά: E. V. Shubnikova, κ.ά.
Έκδοση: (2019-03-01)

Rotavirus Vaccine Withdrawal in the United States: The Role of Postmarketing Surveillance
ανά: Gilles Delage
Έκδοση: (2000-01-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2018)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
ανά: Colleen M. Kingsbury, κ.ά.
Έκδοση: (2024-09-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
ανά: Wei Mao, κ.ά.
Έκδοση: (2025-01-01)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
ανά: Daniele Sartori, κ.ά.
Έκδοση: (2020-08-01)

Postmarket sequential database surveillance of medical products
ανά: Maro, Judith C
Έκδοση: (2013)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
ανά: Yamin Shu, κ.ά.
Έκδοση: (2023-05-01)

Postmarket Surveillance of Neuroendovascular Devices
ανά: Marie K. Luff, κ.ά.
Έκδοση: (2024-03-01)

Postmarket Drug Surveillance Without Trial Costs: Discovery of Adverse Drug Reactions Through Large-Scale Analysis of Web Search Queries
ανά: Yom-Tov, Elad, κ.ά.
Έκδοση: (2013-06-01)

Redefining rapid reviews: a flexible framework for restricted systematic reviews
ανά: Plüddemann, A, κ.ά.
Έκδοση: (2018)

Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
ανά: Jinyi Yuan, κ.ά.
Έκδοση: (2022-12-01)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
ανά: John T. Sullivan
Έκδοση: (2022-04-01)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
ανά: Onakpoya, IJ, κ.ά.
Έκδοση: (2020)

Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013–2017
ανά: Kevin Wing, κ.ά.
Έκδοση: (2019-10-01)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
ανά: Aronson, J
Έκδοση: (2008)

An agenda for research on adverse drug reactions.
ανά: Aronson, J
Έκδοση: (2007)

Adverse drug reactions--no farewell to harms.
ανά: Aronson, J
Έκδοση: (2007)

Pharmacogenetics and adverse drug reactions
ανά: Ferner, R, κ.ά.
Έκδοση: (2010)

Clinical efficacy and safety of alemtuzumab in postmarketing practice
ανά: N. V. Khachanova
Έκδοση: (2019-06-01)

Comparison of Data Mining Methods for the Signal Detection of Adverse Drug Events with a Hierarchical Structure in Postmarketing Surveillance
ανά: Goeun Park, κ.ά.
Έκδοση: (2020-08-01)

Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19
ανά: Pasquale Stefanizzi, κ.ά.
Έκδοση: (2022-01-01)

Postmarketing Surveillance: Review of Open Sources of Drug Safety Data
ανά: E. V. Shubnikova
Έκδοση: (2024-10-01)

Serum trough level as a postmarketing quality measure of generic vancomycin products
ανά: Ya-Wen Tsai, κ.ά.
Έκδοση: (2020-04-01)

The need for randomization in animal trials: an overview of systematic reviews
ανά: Hirst, J, κ.ά.
Έκδοση: (2014)

Orphan Therapies: Making Best Use of Postmarket Data
ανά: Li, Lingling, κ.ά.
Έκδοση: (2016)

Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
ανά: Huqun Li, κ.ά.
Έκδοση: (2025-01-01)

Pharmacoepidemiology – Assessing the Risks and Benefits of Drugs in the Postmarketing Phase
ανά: Christoph R. Meier
Έκδοση: (2006-02-01)

Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: A systematic review and meta-analysis of randomised clinical trials.
ανά: Onakpoya, I, κ.ά.
Έκδοση: (2014)

Adverse drug reactions: definitions, diagnosis, and management.
ανά: Edwards, I, κ.ά.
Έκδοση: (2000)

Reduced salt intake for heart failure: A systematic review
ανά: Mahtani, K, κ.ά.
Έκδοση: (2018)

Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients
ανά: Manuela Vasquez Cardoso, κ.ά.
Έκδοση: (2023-04-01)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
ανά: Loke, Y, κ.ά.
Έκδοση: (2006)